Determination of Extended-Spectrum Beta-Lactamases Genes and Antibiotic Resistance Patterns in Escherichia coli Isolates from Healthy Cats
,
Abstract
Background: This study was set to detect extended-spectrum beta-lactamases (ESBLs) producing E. coli isolates and the genes underlying their resistance in relation to phylogenetic background from fecal samples of healthy owned cats.
Methods: A total of 50 E. coli isolates were confirmed by standard bacteriological tests. The phylogenetic analyses of the isolates were carried out by combinations of three genetic markers chuA, yjaA and DNA fragment TspE4.C2 by a triplex PCR method. The ESBL (blaCTXM, blaTEM, blaSHV, blaOXA) encoding genes were detected. To identify ESBL producing phenotypes, all selected isolates were screened with a double disk synergy test including cefotaxime, cefotaxime with clavulanic acid, ceftazidime and ceftazidime with clavulanic acid.
Results: Results showed that E. coli isolates fell into four phylogenetic groups (A, D, B1 and B2) with prevalence of 78%, 4%, 8%, 10% and five phylogenetic subgroups including A0 (74 %), A1 (4 %), B1 (8 %), B2–2 (6 %), B2–3 (4 %) and D1 (4 %), respectively. Among all E. coli isolates, 4% were positive for blaSHV, blaCTX-M-15 and blaOXA-1 genes which distributed in B2-2, B2-3, A0 subgroups, respectively. According to antibiotic susceptibility test, 20 isolates were resistant which belonged to D (D1 phylogenetic subgroup) and A (A0 phylogenetic subgroup) groups.
Conclusion: The results showed that healthy cats could be considered as potential source for the dissemination of ESBL-encoding genes. Further investigations in companion animals and their owners are needed to clarify the importance of spreading of these zoonotic strains.
Chen YM, Wright PJ, Lee CS, et al. Uropathogenic virulence factors in isolates of Escherichia coli from clinical cases of canine pyometra and feces of healthy bitches. Vet Microbiol 2003; 94(1): 57-69.
Hagman R, Kuhn I. Escherichia coli strains isolated from the uterus and urinary bladder of bitches suffering from pyometra: comparison by restriction enzyme digestion and pulsed-field gel electrophoresis. Vet Microbiol 2002; 84(1-2): 143-153.
Cooke CL, Singer RS, Jang SS, et al. Enrofloxacin resistance in Escherichia coli isolated from dogs with urinary tract infections. J Am Vet Med Assoc 2002; 220(2): 190-192.
Li XZ, Mehrotra M, Ghimire S, et al. β-lactam resistance and β-lactamases in bacteria of animal origin. Vet Microbiol 2007; 121(3-4): 197-214.
Sanchez S, McCrackin Stevenson MA, Hudson CR, et al. Characterization of multidrug-resistant Escherichia coli
jmb.tums.ac.ir
isolates associated with nosocomial infections in dogs. J Clin Microbiol 2002; 40(10): 3586-3595.
Shaheen BW, Boothe DM, Oyarzabal OA, et al. Antimicrobial resistance profiles and clonal relatedness of canine and feline Escherichia coli pathogens expressing multidrug resistance in the United States. J Vet Intern Med 2010; 24(2): 323–330.
Guardabassi L, Schwarz S, Lloyd DH. Pet animals as reservoirs of antimicrobial-resistant bacteria. J Antimicrob Chemother 2004; 54(2): 321–332.
Bradford PA. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001; 14(4): 933–951.
Livermore DM. β-Lactamases in laboratory and clinical resistance. Clin Microbiol Rev 1995; 8(4): 557–584.
Bonnet R. Growing group of extended-spectrum β-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 2004; 48(1): 1– 14.
Brinas L, Lantero M, de Diego I, et al. Mechanisms of resistance to expanded-spectrum cephalosporins in Escherichia coli isolates recovered in a Spanish hospital. J Antimicrob Chemother 2005; 56(6): 1107– 1110.
Brinas L, Moreno MA, Teshager T, et al. Monitoring and characterization of extended-spectrum β-lactamases in Escherichia coli strains from healthy and sick animals in Spain in 2003. Antimicrob Agents Chemother 2005; 49(3): 1262–1264.
Cartelle M, del Mar Tomas M, Molina F, et al. High-level resistance to ceftazidime conferred by a novel enzyme, CTX-M-32, derived from CTX-M-1 through a single Asp240-Gly substitution. Antimicrob. Agents Chemother 2004; 48(6): 2308–2313.
Gonullu N, Aktas Z, kayacan CB, et al. Dissemination of CTX-M-15 β-lactamase genes carried on Inc FI and FII plasmids among clinical isolates of Escherichia coli in a university hospital in Istanbul, Turkey. J Clin Microbiol 2008; 46(3): 1110–1112.
Machado E, Machado E, Coque TM, et al. Dissemination in Portugal of CTX-M-15-, OXA-1-,and TEM-1-producing
Enterobacte-riaceae strains containing the aac(6 )-Ib-cr gene, which encodes an aminoglycoside- and fluoroquinolone-modifying enzyme. Antimicrob Agents Chemother 2006; 50(9): 3220–3221.
Carattoli A, Lovari S, Franco A, et al. Extended-spectrum β-lactamases in Escherichia coli isolated from dogs and cats in Rome, Italy, from 2001 to 2003. Antimicrob Agents Chemother 2005; 49(2): 833–835.
Costa D, Poeta P, Sáenz Y, et al. Prevalence of antimicrobial resistance and resistance genes in faecal Escherichia coli isolates recovered from healthy pets. Vet Microbiol 2008; 127(1-2): 97–105.
Moreno A, Bello H, Guggiana D, et al. Extended-spectrum β-lactamases belonging to CTX-M group produced by Escherichia coli strains isolated from companion animals treated with enrofloxacin. Vet Microbiol 2008; 129(1-2): 203–208.
O’Keefe A, Hutton TA, Schifferli DM, et al. First detection of CTX-M and SHV extended-spectrum β-lactamases in Escherichia coli urinary tract isolates from dogs and cats in the United States. Antimicrob Agents Chemother 2010; 54(8): 3489–3492.
Shaheen BW, Nayak R, Foley SL, et al. Molecular Characterization of Resistance to Extended-Spectrum Cephalosporins in Clinical Escherichia coli Isolates from Companion Animals in the United States. Antimicrob Agents Chemother 2011; 55(12): 5666-5675.
Klintschar M, Neuhuber F. Evaluation of an alkaline lysis method for the extraction of DNA from whole blood and forensic stains for STR analysis. J Forensic Sci 2000; 45(3): 669–673.
Clermont O, Bonacorsi S, Bingen E. Rapid and Simple Determination of the Escherichia coli Phylogenetic Group.Appl Environ Microbiol 2000; 66(10): 4555– 4558.
Koljalg S, Truusalu K, Vainumäe I, et al. Persistence of Escherichia coli clones and phenotypic and genotypic antibiotic resistance in recurrent urinary tract infections in childhood. J Clin Microbiol 2009; 47(1): 99– 105.
Caprioli A, Busani L, Martel JL, et al. Monitoring of antibiotic resistance in bacteria of animal origin: Epidemiological and microbio-logical methodologies. Int J Antimicrob Agents 2000; 14(4): 295-301.
Murphy C, Reid-Smith RJ, Prescott JF, et al. Occurrence of antimicrobial resistant bacteria in healthy dogs and cats presented to private veterinary hospitals in southern Ontario: a preliminary study. Can Vet J 2009; 50(10): 1047–1053.
Gandolfi-Decristophoris P, Petrini O, Ruggeri-Bernardi N, et al. Extended-spectrum betalactamase-producing Enterobacteriaceae in healthy companion animals living in nursing homes and in the community. Am J Infect Control 2013; 41(9): 831-835.
Vengust M, Anderson ME, Rousseau J, et al. Methicillin-resistant staphylococcal colonization in clinically normal dogs and horses in the community. Lett Appl Microbiol 2006; 43(6): 602–606.
Moodley A, Stegger M, Bagcigil AF, et al. spa typing of methicillin resistant Staphylococcus aureus isolated from domestic animals and veterinary staff in the UK and Ireland. J Antimicrob Chemother 2006; 58(6):1118–1123.
Damborg P, Marskar P, Baptiste KE, et al. Faecal shedding of CTX-M-producing Escherichia coli in horses receiving broad-spectrum antimicrobial prophylaxis after hospital admission. Vet Microbiol 2012; 154(3-4): 298–304.
| Files | ||
| Issue | Vol 4 No 5-6 (2015) | |
| Section | Original Articles | |
| Keywords | ||
| Escherichia coli Extended-spectrum β-Lactamase Phylogenetic Group Cat. | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
